Literature DB >> 2456973

Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.

M Cottone1, M Turri, M Caltagirone, A Maringhini, E Sciarrino, R Virdone, G Fusco, A Orlando, L Marino, L Pagliaro.   

Abstract

A prospective surveillance of hepatocellular carcinoma (HCC) associated with cirrhosis, using alfafetoprotein (AFP) and real-time ultrasonography (US) was carried out in 157 patients with histologically proven cirrhosis. During a two-year follow-up, 15 asymptomatic HCCs were identified. HCCs detected by these methods were at a relatively early stage, as most tumors were small (13 out of 15 less than 5 cm). US was more sensitive than AFP in the diagnosis of HCC when values greater than 400 ng/ml were considered. Patients with initial AFP values greater than 20 ng/ml developed HCC within two years more frequently than patients with values less than 20 ng/ml. A combined approach using US and AFP is suggested in our geographical area.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456973

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.

Authors:  G L Rapaccini; M Pompili; E Caturelli; M Anti; A Aliotta; A Cedrone; E Amadei; A Grattagliano; M M Squillante; C Rabitti
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Clinical usefulness of des-gamma-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma.

Authors:  S Fujiyama; K Izuno; K Gohshi; J Shibata; T Sato
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

3.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

Authors:  L Bolondi; S Sofia; S Siringo; S Gaiani; A Casali; G Zironi; F Piscaglia; L Gramantieri; M Zanetti; M Sherman
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes.

Authors:  Peter J Kneuertz; Aram Demirjian; Amin Firoozmand; Celia Corona-Villalobos; Nikhil Bhagat; Joseph Herman; Andrew Cameron; Ahmet Gurakar; David Cosgrove; Michael A Choti; Jean-Francois H Geschwind; Ihab R Kamel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2012-04-03       Impact factor: 5.344

5.  Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.

Authors:  F Izzo; F Cremona; F Ruffolo; R Palaia; V Parisi; S A Curley
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

6.  Percutaneous ethanol injection therapy of hepatoma.

Authors:  T Livraghi; C Vettori
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

7.  Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.

Authors:  L Benvegnù; F Noventa; E Bernardinello; P Pontisso; A Gatta; A Alberti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

8.  Screening for hepatocellular carcinoma.

Authors:  Singal Amit; Marrero Jorge A
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

9.  Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.

Authors:  J Raedle; W K Roth; G Oremek; W F Caspary; S Zeuzem
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

10.  Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.

Authors:  S A Curley; F Izzo; A Gallipoli; M de Bellis; F Cremona; V Parisi
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.